Global Anti-Obesity Drugs (Anti-obesity Medication) Market Research Report 2024, Forecast to 2032
Report Overview
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
The global Anti-Obesity Drugs (Anti-obesity Medication) market size was estimated at USD 1824.10 million in 2023 and is projected to reach USD 7494.13 million by 2032, exhibiting a CAGR of 17.00% during the forecast period.
North America Anti-Obesity Drugs (Anti-obesity Medication) market size was estimated at USD 623.92 million in 2023, at a CAGR of 14.57% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Anti-Obesity Drugs (Anti-obesity Medication) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Obesity Drugs (Anti-obesity Medication) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Obesity Drugs (Anti-obesity Medication) market in any manner.
Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Market Segmentation (by Type)
Prescription Drugs
OTC Drugs
Market Segmentation (by Application)
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Obesity Drugs (Anti-obesity Medication) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-Obesity Drugs (Anti-obesity Medication), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
The global Anti-Obesity Drugs (Anti-obesity Medication) market size was estimated at USD 1824.10 million in 2023 and is projected to reach USD 7494.13 million by 2032, exhibiting a CAGR of 17.00% during the forecast period.
North America Anti-Obesity Drugs (Anti-obesity Medication) market size was estimated at USD 623.92 million in 2023, at a CAGR of 14.57% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Anti-Obesity Drugs (Anti-obesity Medication) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Obesity Drugs (Anti-obesity Medication) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Obesity Drugs (Anti-obesity Medication) market in any manner.
Global Anti-Obesity Drugs (Anti-obesity Medication) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Zafgan
Vivus
Shionogi
Sanofi
Rhythm Pharmaceuticals
Pfizer
Orexigen Therapeutics
Novo Nordisk
Norgine
Nalpropion Pharmaceuticals Inc.
Merck
GlaxoSmithKline
F.Hoffmann-La Roche
Eisai
Boehringer Ingelheim
Bayer AG
AstraZeneca
Arena Pharmaceuticals
Amylin
Alizyme
Market Segmentation (by Type)
Prescription Drugs
OTC Drugs
Market Segmentation (by Application)
Childhood (0-6)
Juvenile (7-17)
Youth (18-40)
Middle Aged (41-60)
Elderly (Above 60)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-Obesity Drugs (Anti-obesity Medication) Market
- Overview of the regional outlook of the Anti-Obesity Drugs (Anti-obesity Medication) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Obesity Drugs (Anti-obesity Medication) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-Obesity Drugs (Anti-obesity Medication), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-Obesity Drugs (Anti-obesity Medication)
1.2 Key Market Segments
1.2.1 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type
1.2.2 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2019-2024)
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Sales Sites, Area Served, Product Type
3.6 Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Situation and Trends
3.6.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) INDUSTRY CHAIN ANALYSIS
4.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2019-2024)
6.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2019-2024)
7 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Sales by Application (2019-2024)
7.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET CONSUMPTION BY REGION
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-Obesity Drugs (Anti-obesity Medication) by Region (2019-2024)
9.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2019-2024)
9.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-Obesity Drugs (Anti-obesity Medication) Production
9.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production
9.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (2019-2024)
9.6.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.6.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-Obesity Drugs (Anti-obesity Medication) Production (2019-2024)
9.7.1 China Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.7.2 China Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Zafgan
10.1.1 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.1.2 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.1.4 Zafgan Business Overview
10.1.5 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
10.1.6 Zafgan Recent Developments
10.2 Vivus
10.2.1 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.2.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.2.4 Vivus Business Overview
10.2.5 Vivus Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
10.2.6 Vivus Recent Developments
10.3 Shionogi
10.3.1 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.3.2 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
10.3.5 Shionogi Business Overview
10.3.6 Shionogi Recent Developments
10.4 Sanofi
10.4.1 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.4.2 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Rhythm Pharmaceuticals
10.5.1 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.5.2 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.5.4 Rhythm Pharmaceuticals Business Overview
10.5.5 Rhythm Pharmaceuticals Recent Developments
10.6 Pfizer
10.6.1 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.6.2 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.7.2 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.7.4 Orexigen Therapeutics Business Overview
10.7.5 Orexigen Therapeutics Recent Developments
10.8 Novo Nordisk
10.8.1 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.8.2 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.8.4 Novo Nordisk Business Overview
10.8.5 Novo Nordisk Recent Developments
10.9 Norgine
10.9.1 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.9.2 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.9.4 Norgine Business Overview
10.9.5 Norgine Recent Developments
10.10 Nalpropion Pharmaceuticals Inc.
10.10.1 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.10.2 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.10.4 Nalpropion Pharmaceuticals Inc. Business Overview
10.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments
10.11 Merck
10.11.1 Merck Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 GlaxoSmithKline
10.12.1 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.12.4 GlaxoSmithKline Business Overview
10.12.5 GlaxoSmithKline Recent Developments
10.13 F.Hoffmann-La Roche
10.13.1 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.13.4 F.Hoffmann-La Roche Business Overview
10.13.5 F.Hoffmann-La Roche Recent Developments
10.14 Eisai
10.14.1 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.14.2 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.14.4 Eisai Business Overview
10.14.5 Eisai Recent Developments
10.15 Boehringer Ingelheim
10.15.1 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.15.2 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.15.4 Boehringer Ingelheim Business Overview
10.15.5 Boehringer Ingelheim Recent Developments
10.16 Bayer AG
10.16.1 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.16.2 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.16.4 Bayer AG Business Overview
10.16.5 Bayer AG Recent Developments
10.17 AstraZeneca
10.17.1 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.17.2 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.17.4 AstraZeneca Business Overview
10.17.5 AstraZeneca Recent Developments
10.18 Arena Pharmaceuticals
10.18.1 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.18.2 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.18.4 Arena Pharmaceuticals Business Overview
10.18.5 Arena Pharmaceuticals Recent Developments
10.19 Amylin
10.19.1 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.19.2 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.19.4 Amylin Business Overview
10.19.5 Amylin Recent Developments
10.20 Alizyme
10.20.1 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.20.2 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.20.4 Alizyme Business Overview
10.20.5 Alizyme Recent Developments
11 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET FORECAST BY REGION
11.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast
11.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region
11.2.4 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Anti-Obesity Drugs (Anti-obesity Medication) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2025-2032)
12.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2025-2032)
12.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Application (2025-2032)
12.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application
12.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-Obesity Drugs (Anti-obesity Medication)
1.2 Key Market Segments
1.2.1 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Type
1.2.2 Anti-Obesity Drugs (Anti-obesity Medication) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers (2019-2024)
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Sales Sites, Area Served, Product Type
3.6 Anti-Obesity Drugs (Anti-obesity Medication) Market Competitive Situation and Trends
3.6.1 Anti-Obesity Drugs (Anti-obesity Medication) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Obesity Drugs (Anti-obesity Medication) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) INDUSTRY CHAIN ANALYSIS
4.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2019-2024)
6.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2019-2024)
7 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Sales by Application (2019-2024)
7.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET CONSUMPTION BY REGION
8.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET PRODUCTION BY REGION
9.1 Global Production of Anti-Obesity Drugs (Anti-obesity Medication) by Region (2019-2024)
9.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2019-2024)
9.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Anti-Obesity Drugs (Anti-obesity Medication) Production
9.4.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.4.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production
9.5.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.5.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (2019-2024)
9.6.1 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.6.2 Japan Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Anti-Obesity Drugs (Anti-obesity Medication) Production (2019-2024)
9.7.1 China Anti-Obesity Drugs (Anti-obesity Medication) Production Growth Rate (2019-2024)
9.7.2 China Anti-Obesity Drugs (Anti-obesity Medication) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Zafgan
10.1.1 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.1.2 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.1.4 Zafgan Business Overview
10.1.5 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
10.1.6 Zafgan Recent Developments
10.2 Vivus
10.2.1 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.2.2 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.2.4 Vivus Business Overview
10.2.5 Vivus Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
10.2.6 Vivus Recent Developments
10.3 Shionogi
10.3.1 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.3.2 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
10.3.5 Shionogi Business Overview
10.3.6 Shionogi Recent Developments
10.4 Sanofi
10.4.1 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.4.2 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Rhythm Pharmaceuticals
10.5.1 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.5.2 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.5.4 Rhythm Pharmaceuticals Business Overview
10.5.5 Rhythm Pharmaceuticals Recent Developments
10.6 Pfizer
10.6.1 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.6.2 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.7.2 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.7.4 Orexigen Therapeutics Business Overview
10.7.5 Orexigen Therapeutics Recent Developments
10.8 Novo Nordisk
10.8.1 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.8.2 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.8.4 Novo Nordisk Business Overview
10.8.5 Novo Nordisk Recent Developments
10.9 Norgine
10.9.1 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.9.2 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.9.4 Norgine Business Overview
10.9.5 Norgine Recent Developments
10.10 Nalpropion Pharmaceuticals Inc.
10.10.1 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.10.2 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.10.4 Nalpropion Pharmaceuticals Inc. Business Overview
10.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments
10.11 Merck
10.11.1 Merck Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.11.2 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 GlaxoSmithKline
10.12.1 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.12.2 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.12.4 GlaxoSmithKline Business Overview
10.12.5 GlaxoSmithKline Recent Developments
10.13 F.Hoffmann-La Roche
10.13.1 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.13.2 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.13.4 F.Hoffmann-La Roche Business Overview
10.13.5 F.Hoffmann-La Roche Recent Developments
10.14 Eisai
10.14.1 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.14.2 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.14.4 Eisai Business Overview
10.14.5 Eisai Recent Developments
10.15 Boehringer Ingelheim
10.15.1 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.15.2 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.15.4 Boehringer Ingelheim Business Overview
10.15.5 Boehringer Ingelheim Recent Developments
10.16 Bayer AG
10.16.1 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.16.2 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.16.4 Bayer AG Business Overview
10.16.5 Bayer AG Recent Developments
10.17 AstraZeneca
10.17.1 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.17.2 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.17.4 AstraZeneca Business Overview
10.17.5 AstraZeneca Recent Developments
10.18 Arena Pharmaceuticals
10.18.1 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.18.2 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.18.4 Arena Pharmaceuticals Business Overview
10.18.5 Arena Pharmaceuticals Recent Developments
10.19 Amylin
10.19.1 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.19.2 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.19.4 Amylin Business Overview
10.19.5 Amylin Recent Developments
10.20 Alizyme
10.20.1 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
10.20.2 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
10.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Market Performance
10.20.4 Alizyme Business Overview
10.20.5 Alizyme Recent Developments
11 ANTI-OBESITY DRUGS (ANTI-OBESITY MEDICATION) MARKET FORECAST BY REGION
11.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast
11.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region
11.2.4 South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Anti-Obesity Drugs (Anti-obesity Medication) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2025-2032)
12.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2025-2032)
12.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Forecast by Application (2025-2032)
12.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application
12.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-Obesity Drugs (Anti-obesity Medication) Market Size Comparison by Region (M USD)
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2022)
Table 10. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Sales Sites and Area Served
Table 12. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-Obesity Drugs (Anti-obesity Medication)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (K MT)
Table 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (M USD)
Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Type (2019-2024)
Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2019-2024)
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Share by Type (2019-2024)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/MT) by Type (2019-2024)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Application
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2019-2024) & (K MT)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2019-2024)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2019-2024)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2019-2024) & (K MT)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2019-2024)
Table 38. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2019-2024) & (K MT)
Table 39. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2019-2024) & (K MT)
Table 41. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2019-2024) & (K MT)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) by Region (2019-2024)
Table 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 52. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 53. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Zafgan Business Overview
Table 55. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 56. Zafgan Recent Developments
Table 57. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 58. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 59. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Vivus Business Overview
Table 61. Vivus Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 62. Vivus Recent Developments
Table 63. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 64. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 65. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 67. Shionogi Business Overview
Table 68. Shionogi Recent Developments
Table 69. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 70. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 71. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Sanofi Business Overview
Table 73. Sanofi Recent Developments
Table 74. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 75. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 76. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Rhythm Pharmaceuticals Business Overview
Table 78. Rhythm Pharmaceuticals Recent Developments
Table 79. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 80. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 81. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 85. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 86. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Orexigen Therapeutics Business Overview
Table 88. Orexigen Therapeutics Recent Developments
Table 89. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 90. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 91. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Novo Nordisk Business Overview
Table 93. Novo Nordisk Recent Developments
Table 94. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 95. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 96. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Norgine Business Overview
Table 98. Norgine Recent Developments
Table 99. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 100. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 101. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Nalpropion Pharmaceuticals Inc. Business Overview
Table 103. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 104. Merck Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 105. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 106. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Merck Business Overview
Table 108. Merck Recent Developments
Table 109. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 110. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 111. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Recent Developments
Table 114. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 115. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 116. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. F.Hoffmann-La Roche Business Overview
Table 118. F.Hoffmann-La Roche Recent Developments
Table 119. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 120. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 121. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Eisai Business Overview
Table 123. Eisai Recent Developments
Table 124. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 125. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 126. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Boehringer Ingelheim Business Overview
Table 128. Boehringer Ingelheim Recent Developments
Table 129. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 130. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 131. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Bayer AG Business Overview
Table 133. Bayer AG Recent Developments
Table 134. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 135. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 136. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. AstraZeneca Business Overview
Table 138. AstraZeneca Recent Developments
Table 139. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 140. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 141. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Arena Pharmaceuticals Business Overview
Table 143. Arena Pharmaceuticals Recent Developments
Table 144. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 145. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 146. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Amylin Business Overview
Table 148. Amylin Recent Developments
Table 149. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 150. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 151. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Alizyme Business Overview
Table 153. Alizyme Recent Developments
Table 154. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-Obesity Drugs (Anti-obesity Medication) Market Size Comparison by Region (M USD)
Table 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Drugs (Anti-obesity Medication) as of 2022)
Table 10. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Sales Sites and Area Served
Table 12. Manufacturers Anti-Obesity Drugs (Anti-obesity Medication) Product Type
Table 13. Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-Obesity Drugs (Anti-obesity Medication)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
Table 22. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (K MT)
Table 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type (M USD)
Table 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Type (2019-2024)
Table 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2019-2024)
Table 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Share by Type (2019-2024)
Table 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Price (USD/MT) by Type (2019-2024)
Table 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) by Application
Table 30. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
Table 31. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2019-2024) & (K MT)
Table 32. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2019-2024)
Table 33. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2019-2024)
Table 35. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2019-2024) & (K MT)
Table 37. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2019-2024)
Table 38. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2019-2024) & (K MT)
Table 39. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2019-2024) & (K MT)
Table 41. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2019-2024) & (K MT)
Table 43. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) by Region (2019-2024)
Table 44. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Region (2019-2024)
Table 46. Global Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 52. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 53. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Zafgan Business Overview
Table 55. Zafgan Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 56. Zafgan Recent Developments
Table 57. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 58. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 59. Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Vivus Business Overview
Table 61. Vivus Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 62. Vivus Recent Developments
Table 63. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 64. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 65. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Shionogi Anti-Obesity Drugs (Anti-obesity Medication) SWOT Analysis
Table 67. Shionogi Business Overview
Table 68. Shionogi Recent Developments
Table 69. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 70. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 71. Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Sanofi Business Overview
Table 73. Sanofi Recent Developments
Table 74. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 75. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 76. Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Rhythm Pharmaceuticals Business Overview
Table 78. Rhythm Pharmaceuticals Recent Developments
Table 79. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 80. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 81. Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 85. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 86. Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Orexigen Therapeutics Business Overview
Table 88. Orexigen Therapeutics Recent Developments
Table 89. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 90. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 91. Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Novo Nordisk Business Overview
Table 93. Novo Nordisk Recent Developments
Table 94. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 95. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 96. Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Norgine Business Overview
Table 98. Norgine Recent Developments
Table 99. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 100. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 101. Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Nalpropion Pharmaceuticals Inc. Business Overview
Table 103. Nalpropion Pharmaceuticals Inc. Recent Developments
Table 104. Merck Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 105. Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 106. Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Merck Business Overview
Table 108. Merck Recent Developments
Table 109. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 110. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 111. GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Recent Developments
Table 114. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 115. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 116. F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. F.Hoffmann-La Roche Business Overview
Table 118. F.Hoffmann-La Roche Recent Developments
Table 119. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 120. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 121. Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Eisai Business Overview
Table 123. Eisai Recent Developments
Table 124. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 125. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 126. Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Boehringer Ingelheim Business Overview
Table 128. Boehringer Ingelheim Recent Developments
Table 129. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 130. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 131. Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Bayer AG Business Overview
Table 133. Bayer AG Recent Developments
Table 134. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 135. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 136. AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. AstraZeneca Business Overview
Table 138. AstraZeneca Recent Developments
Table 139. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 140. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 141. Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Arena Pharmaceuticals Business Overview
Table 143. Arena Pharmaceuticals Recent Developments
Table 144. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 145. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 146. Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Amylin Business Overview
Table 148. Amylin Recent Developments
Table 149. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Basic Information
Table 150. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Overview
Table 151. Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Alizyme Business Overview
Table 153. Alizyme Recent Developments
Table 154. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD), 2019-2032
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) (2019-2032)
Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (M USD)
Figure 11. Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers in 2023
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers in 2023
Figure 13. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type
Figure 18. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2019-2024)
Figure 19. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2023
Figure 20. Market Size Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application
Figure 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2023
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2019-2024)
Figure 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application in 2023
Figure 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2023
Figure 32. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2023
Figure 37. Germany Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2023
Figure 44. China Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 50. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2023
Figure 51. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Market Share by Region (2019-2024)
Figure 62. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 65. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Anti-Obesity Drugs (Anti-obesity Medication)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD), 2019-2032
Figure 5. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size (M USD) (2019-2032)
Figure 6. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country (M USD)
Figure 11. Anti-Obesity Drugs (Anti-obesity Medication) Sales Share by Manufacturers in 2023
Figure 12. Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Share by Manufacturers in 2023
Figure 13. Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-Obesity Drugs (Anti-obesity Medication) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Type
Figure 18. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2019-2024)
Figure 19. Sales Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2023
Figure 20. Market Size Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-Obesity Drugs (Anti-obesity Medication) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application
Figure 24. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application in 2023
Figure 26. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application (2019-2024)
Figure 27. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Application in 2023
Figure 28. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2023
Figure 32. U.S. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Anti-Obesity Drugs (Anti-obesity Medication) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-Obesity Drugs (Anti-obesity Medication) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2023
Figure 37. Germany Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2023
Figure 44. China Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 50. South America Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Country in 2023
Figure 51. Brazil Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Anti-Obesity Drugs (Anti-obesity Medication) Production Market Share by Region (2019-2024)
Figure 62. North America Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 65. China Anti-Obesity Drugs (Anti-obesity Medication) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Type (2025-2032)
Figure 70. Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Forecast by Application (2025-2032)
Figure 71. Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share Forecast by Application (2025-2032)
